Singapore legislation

Regulation 2

of Pharmacists Registration (Exemption) Order 2018

Regulation 2

Exemption

Amended byS 402/2023 wef 26/06/2023S 576/2018 wef 17/09/2018S 402/2023 wef 26/06/2023S 576/2018 wef 17/09/2018S 402/2023 wef 26/06/2023

Subregulation 1

Amended byS 402/2023 wef 26/06/2023S 576/2018 wef 17/09/2018S 402/2023 wef 26/06/2023S 576/2018 wef 17/09/2018

Section 28(1)(a) of the Act does not apply to a collaborative prescribing practitioner if —

(a)

the collaborative prescribing practitioner provides a collaborative prescribing service for and on behalf of an approved person, in accordance with the Healthcare Services (Collaborative Prescribing Service) Regulations 2023 (G.N. No. S 398/2023); and

(b)

for the purpose, or in the course, of providing the collaborative prescribing service, the collaborative prescribing practitioner does any of the following in accordance with his or her collaborative practice agreement with the approved person:

(i)

administers medication;

(ii)

initiates or modifies medication therapy;

(iii)

manages medication therapy.

Subregulation 2

Amended byS 402/2023 wef 26/06/2023

In this paragraph —

Definition

“approved person” means a person who is —

(a)

authorised by a licence under the Healthcare Services Act 2020 to provide a licensable healthcare service within the meaning of that Act; and

(b)

approved under section 11D of that Act to provide a collaborative prescribing service;

Definition

“collaborative practice agreement”, “collaborative prescribing practitioner” and “collaborative prescribing service” have the meanings given by regulation 2 of the Healthcare Services (Collaborative Prescribing Service) Regulations 2023.